Literature DB >> 27035337

Co‑inhibition of miRNA‑21 and miRNA‑221 induces apoptosis by enhancing the p53‑mediated expression of pro‑apoptotic miRNAs in laryngeal squamous cell carcinoma.

Xuan Kan1, Yanan Sun1, Jianguang Lu1, Minghua Li1, Yu Wang1, Qiuying Li1, Ying Liu1, Ming Liu1, Linli Tian1.   

Abstract

Dysregulation of a numerous microRNAs (miRNAs) has been implicated in laryngeal squamous cell carcinoma (LSCC). Among those miRNAs, miR‑21 and miR‑221 are co‑overexpressed and commonly target the phosphatase and tensin homolog protein (PTEN) that is located in the PTENAkt signaling pathway. The present study investigated whether co‑inhibition of miR‑21 and miR‑221 induced synergistic apoptosis of human LSCC cells. Methyl thiazolyl tetrazolium (MTT) and terminal deoxynucleotidyl‑transferase‑mediated deoxynucleotide triphosphate nick end labeling (TUNEL) assays were used to observe the potential effect of miR‑21 and miR‑221 on cell viability and apoptosis in cells co‑transfected with anti‑miRNA oligonucleotide (AMO)‑21 and AMO‑221. The protein expression levels of PTEN, Akt and p53 were determined by western blotting. The cellular abundance of 6 pro‑apoptotic miRNAs transcribed by p53 mediation, consisting of miR‑15a, miR‑16‑1, miR‑26a, miR‑34a, miR‑143 and miR‑203, was measured with using reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR). MTT results indicate that in vitro co‑transfection of AMO‑21 and AMO‑221 leads to a decline in cell viability, compared with the transfection of AMO alone. This result was verified by the detection of apoptosis using TUNEL assays. Co‑transfection of AMO‑21 and AMO‑221 resulted in a marked reduction in Akt phosphorylation and enhanced expression of PTEN and p53 were observed; consequently, leading to an amplification of the transcription of 6 pro‑apoptotic miRNAs. The present findings confirmed that co‑inhibition of miR‑21 and miR‑221 synergistically triggers cell apoptosis in vitro. The altered PTENAkt signaling and p53‑mediated amplification of the transcription of pro‑apoptotic miRNAs may be involved in the observed synergistic effect. The present study provides novel insights into the mechanism underlying apoptosis‑associated miRNA‑miRNA mutual regulation in LSCC.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27035337     DOI: 10.3892/mmr.2016.5048

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  9 in total

Review 1.  Levels of MicroRNA Heterogeneity in Cancer Biology.

Authors:  Nina Petrovic; Sercan Ergün; Esma R Isenovic
Journal:  Mol Diagn Ther       Date:  2017-10       Impact factor: 4.074

2.  Comparative miRNA Expression Profile Analysis of Squamous Cell Carcinoma and Peritumoral Mucosa from the Meso- and Hypopharynx.

Authors:  Eva Orosz; Katalin Gombos; Tamas Riedling; Priscilla Afiakurue; Istvan Kiss; Jozsef Pytel; Imre Gerlinger; Istvan Szanyi
Journal:  Cancer Genomics Proteomics       Date:  2017 Jul-Aug       Impact factor: 4.069

3.  Analysis of gene expression profiling variations induced by hsa‑miR‑145‑5p‑overexpression in laryngeal squamous cell carcinoma cell line Tu‑177.

Authors:  Yongxia Ding; Yongyan Wu; Wei Gao; Chunming Zhang; Qinli Zhao; Huina Guo; Xukuan Qu; Shuxin Wen; Binquan Wang
Journal:  Mol Med Rep       Date:  2017-08-24       Impact factor: 2.952

4.  MicroRNA-664 suppresses the growth of cervical cancer cells via targeting c-Kit.

Authors:  Mingfen Lv; Rongying Ou; Qianwen Zhang; Fan Lin; Xiangyun Li; Keyu Wang; Yunsheng Xu
Journal:  Drug Des Devel Ther       Date:  2019-07-17       Impact factor: 4.162

5.  MicroRNA-421 improves ischemia/reperfusion injury via regulation toll-like receptor 4 pathway.

Authors:  Lin-Lin Guo; Ming-Lei Guo; Jian Yao; Yun-Qi Weng; Xue-Zhi Zhang
Journal:  J Int Med Res       Date:  2019-12-18       Impact factor: 1.671

6.  A Super-Enhancer Driven by FOSL1 Controls miR-21-5p Expression in Head and Neck Squamous Cell Carcinoma.

Authors:  Yuehan Wan; Rosalie G Hoyle; Nan Xie; Wenjin Wang; Hongshi Cai; Ming Zhang; Zhikun Ma; Gan Xiong; Xiuyun Xu; Zhengxian Huang; Xiqiang Liu; Jiong Li; Cheng Wang
Journal:  Front Oncol       Date:  2021-04-16       Impact factor: 6.244

7.  Functional Tumor Targeting Nano-Systems for Reprogramming Circulating Tumor Cells with In Situ Evaluation on Therapeutic Efficiency at the Single-Cell Level.

Authors:  Xiao-He Ren; Xiao-Yan He; Chang Xu; Di Han; Si-Xue Cheng
Journal:  Adv Sci (Weinh)       Date:  2022-05-20       Impact factor: 17.521

8.  Biomimetic Nanosystems for the Synergistic Delivery of miR-144/451a for Oral Squamous Cell Carcinoma

Authors:  Kunshan Li; Yongle Qiu; Xin Liu; Fang Huang
Journal:  Balkan Med J       Date:  2022-03-25       Impact factor: 3.570

9.  Smooth muscle cells differentiated from mesenchymal stem cells are regulated by microRNAs and suitable for vascular tissue grafts.

Authors:  Wenduo Gu; Xuechong Hong; Alexandra Le Bras; Witold N Nowak; Shirin Issa Bhaloo; Jiacheng Deng; Yao Xie; Yanhua Hu; Xiong Z Ruan; Qingbo Xu
Journal:  J Biol Chem       Date:  2018-04-11       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.